Stanniocalcin‐2 inhibits skeletal muscle growth and is upregulated in functional overload‐induced hypertrophy
Physiological Reports · 2023
DOI: 10.14814/phy2.15793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Arimantas Lionikas und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor Binding Protein 4, Peptide Hormones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Wellcome Trust, Chief Scientist Office.
Abstract (Originalsprache)
Aims
Stanniocalcin‐2 (STC2) has recently been implicated in human muscle mass variability by genetic analysis. Biochemically, STC2 inhibits the proteolytic activity of the metalloproteinase PAPP‐A, which promotes muscle growth by upregulating the insulin‐like growth factor (IGF) axis. The aim was to examine if STC2 affects skeletal muscle mass and to assess how the IGF axis mediates muscle hypertrophy induced by functional overload.
Methods
We compared muscle mass and muscle fiber morphology between Stc2 −/− ( n = 21) and wild‐type ( n = 15) mice. We then quantified IGF1, IGF2, IGF binding proteins −4 and −5 (IGFBP‐4, IGFBP‐5), PAPP‐A and STC2 in plantaris muscles of wild‐type mice subjected to 4‐week unilateral overload ( n = 14).
Results
Stc2 −/− mice showed up to 10% larger muscle mass compared with wild‐type mice. This increase was mediated by greater cross‐sectional area of muscle fibers. Overload increased plantaris mass and components of the IGF axis, including quantities of IGF1 (by 2.41‐fold, p = 0.0117), IGF2 (1.70‐fold, p = 0.0461), IGFBP‐4 (1.48‐fold, p = 0.0268), PAPP‐A (1.30‐fold, p = 0.0154) and STC2 (1.28‐fold, p = 0.019).
Conclusion
Here we provide evidence that STC2 is an inhibitor of muscle growth upregulated, along with other components of the IGF axis, during overload‐induced muscle hypertrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
- Centre for Heart Lung Innovation, University of British Columbia, St. Paul's Hospital, Vancouver, Canada.
- Department of Health Promotion and Rehabilitation, Lithuanian Sports University, Kaunas, Lithuania.
- The New Zealand Institute for Plant & Food Research Limited, Palmerston North, New Zealand.
- Animal Genetics Company (AnGeCo), Edinburgh, Scotland.
- Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Arimantas Lionikas
Förderung
- Biotechnology and Biological Sciences Research Council
- Wellcome Trust
- Chief Scientist Office
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Danmarks Frie Forskningsfond
Zitieren
APA
Lionikas, A., Hernandez Cordero, A. I., Kilikevicius, A., Carroll, A. M., Bewick, G. S., Bunger, L., Ratkevicius, A., Heisler, L. K., Harboe, M., & Oxvig, C. (2023). Stanniocalcin‐2 inhibits skeletal muscle growth and is upregulated in functional overload‐induced hypertrophy. Physiological Reports. https://doi.org/10.14814/phy2.15793
Vancouver
Lionikas A, Hernandez Cordero AI, Kilikevicius A, Carroll AM, Bewick GS, Bunger L, et al. Stanniocalcin‐2 inhibits skeletal muscle growth and is upregulated in functional overload‐induced hypertrophy. Physiological Reports. 2023. doi:10.14814/phy2.15793
BibTeX
@article{Lionikas2023,
author = {Lionikas, Arimantas and Hernandez Cordero, Ana I and Kilikevicius, Audrius and Carroll, Andrew M and Bewick, Guy S and Bunger, Lutz and Ratkevicius, Aivaras and Heisler, Lora K and Harboe, Mette and Oxvig, Claus},
title = {Stanniocalcin‐2 inhibits skeletal muscle growth and is upregulated in functional overload‐induced hypertrophy},
journal = {Physiological Reports},
year = {2023},
doi = {10.14814/phy2.15793}
}
EUVIMED